相关实验视频

Updated: Jan 16, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

阿迪波涅克受体激活剂减少 brojler 肝脂沉积

Wenhao Tan¹, Kunyu Jiang¹, Yuhan Zhang¹

¹Joint International Research Laboratory of Animal Health and Animal Food Safety, College of Veterinary Medicine, Southwest University, Chongqing, China.

Frontiers in veterinary science

|October 6, 2025

概括

阿迪波龙通过减少肝脏脂肪积累,有效地对抗的脂肪肝综合征 (FLS). 这种化合物通过激活PPARα和抑制脂质合成而起作用,为FLS提供了潜在的治疗策略.

科学领域:

动物科学动物科学
生物化学生物化学
细胞生物学细胞生物学

背景情况:

脂肪肝综合征 (FLS) 是家禽生产的一个重大问题.
已知皮质 (CORT) 可以诱导FLS.
了解FLS背后的分子机制对于开发有效治疗方法至关重要.

研究的目的:

研究AdipoRon在改善肉中CORT诱导的脂肪肝中的疗效.
在体外和体内探索AdipoRon对脂质代谢途径的影响.

主要方法:

在Cobb肉中使用CORT诱导脂肪肝模型进行的一项体内研究.
一项使用脂肪乳液诱导模型在Leghorn男性肝瘤 (LMH) 细胞中的体外研究.
分析与脂质代谢和炎症相关的关键蛋白质表达.

主要成果:

在接受CORT治疗的肉中,AdipoRon显著降低了肝脏脂肪含量.
在体内,AdipoRon增加了PPARα和氨酸 (ADPN) 的表达,同时降低了ACC和p-JNK1.
在体外,AdipoRon降低了脂质积累,降低了ACC和TNF-α的表达,并增强了PPARα,AMPK酸化和CPT-1.

结论:

阿迪波隆在减少FLS肉中的肝脂沉积方面显示出显著的潜力.
该机制涉及PPARα激活和通过ACC降低调节抑制脂质合成.
艾迪波龙可以作为治疗药物,用于管理家禽脂肪肝疾病.

关键词:

作为阿迪波内克因受体的激活剂.brojler 肉肉是一个的肝细胞癌细胞癌.皮质氨酸皮质氨酸是什么脂肪肝综合征脂肪肝综合征

更多相关视频

Isolation of Preadipocytes from Broiler Chick Embryos

Isolation of Preadipocytes from Broiler Chick Embryos

Published on: August 4, 2022

Isolation and Differentiation of Adipose-Derived Stem Cells from Porcine Subcutaneous Adipose Tissues

Isolation and Differentiation of Adipose-Derived Stem Cells from Porcine Subcutaneous Adipose Tissues

Published on: March 31, 2016

相关概念视频

Lipid Absorption

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...